Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Bogin

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Contemporary Clinical Trials Communications|May 13, 2020
Master protocols: New directions in drug discoveryVladimir Bogin
Contemporary Clinical Trials Communications|February 24, 2022
Lasagna's law: A dish best served earlyVladimir Bogin
European Journal of Gastroenterology & Hepatology|January 14, 2005
Budd-Chiari syndrome: in evolutionVladimir Bogin, Amadeo Marcos, Thomas Shaw-Stiffel
The Primary Care Companion for CNS Disorders|September 21, 2019
Combining Xenon Inhalation With Trauma Memory Reactivation to Reduce Symptoms of Posttraumatic Stress Disorder: Case Report, Justification of Approach, and Review of the LiteratureAlexander Dobrovolsky, Vladimir Bogin, Edward G Meloni
Journal of Translational Medicine|June 15, 2017
Xenon in the treatment of panic disorder: an open label studyAlexander Dobrovolsky, Thomas E Ichim, Daqing Ma, et al.
Journal of Translational Medicine|October 9, 2012
Comparison of endometrial regenerative cells and bone marrow stromal cellsHuan Wang, Ping Jin, Marianna Sabatino, et al.
Oncotarget|April 14, 2017
Induction and characterization of anti-tumor endothelium immunity elicited by ValloVax therapeutic cancer vaccineSamuel C Wagner, Thomas E Ichim, Vladimir Bogin, et al.
Journal of Translational Medicine|March 21, 2013
Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinicLeo Bockeria, Vladimir Bogin, Olga Bockeria, et al.
Journal of Translational Medicine|April 1, 2011
Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapyWenxue Ma, Trevor Smith, Vladimir Bogin, et al.
Journal of Translational Medicine|October 30, 2015
Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?Samuel C Wagner, Thomas E Ichim, Hong Ma, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Contemporary Clinical Trials Communications|May 13, 2020
Master protocols: New directions in drug discoveryVladimir Bogin
Contemporary Clinical Trials Communications|February 24, 2022
Lasagna's law: A dish best served earlyVladimir Bogin
European Journal of Gastroenterology & Hepatology|January 14, 2005
Budd-Chiari syndrome: in evolutionVladimir Bogin, Amadeo Marcos, Thomas Shaw-Stiffel
The Primary Care Companion for CNS Disorders|September 21, 2019
Combining Xenon Inhalation With Trauma Memory Reactivation to Reduce Symptoms of Posttraumatic Stress Disorder: Case Report, Justification of Approach, and Review of the LiteratureAlexander Dobrovolsky, Vladimir Bogin, Edward G Meloni
Journal of Translational Medicine|June 15, 2017
Xenon in the treatment of panic disorder: an open label studyAlexander Dobrovolsky, Thomas E Ichim, Daqing Ma, et al.
Journal of Translational Medicine|October 9, 2012
Comparison of endometrial regenerative cells and bone marrow stromal cellsHuan Wang, Ping Jin, Marianna Sabatino, et al.
Oncotarget|April 14, 2017
Induction and characterization of anti-tumor endothelium immunity elicited by ValloVax therapeutic cancer vaccineSamuel C Wagner, Thomas E Ichim, Vladimir Bogin, et al.
Journal of Translational Medicine|March 21, 2013
Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinicLeo Bockeria, Vladimir Bogin, Olga Bockeria, et al.
Journal of Translational Medicine|April 1, 2011
Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapyWenxue Ma, Trevor Smith, Vladimir Bogin, et al.
Journal of Translational Medicine|October 30, 2015
Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?Samuel C Wagner, Thomas E Ichim, Hong Ma, et al.
Pageof 2